Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee.

Slides:



Advertisements
Similar presentations
T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Advertisements

Polyps – Where do they come from and what do you do with them?!
Neuroendocrine tumours of the stomach Case discussion.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
The Adenoma/Carcinoma Sequence in the Colon
Impact of Lymph-Node Metastatic Site in Patients with Thoracic Esophageal Cancer Edited by: Kunisaki C., Makino H., Kimura J., Oshima T., Fujii S., Takagawa.
Management of Difficult Colonic Lesions
AJCC 7th Edition of Gastric Cancer: good enough?
 - an important step in surgical staging for uterine cancer (FIGO 1988)  Stated as 
Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Malignant colonic polyp: endoscopic treatment updates
Dr. LF Hung Department of Surgery, Tuen Mun Hospital, HKSAR
Reporting and Management of Early stage Colorectal Cancer Frank Carey Dundee.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Melanoma Hai Ho, M.D. Department of Family Practice.
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
G.Liguori,G.Pirozzi^, I. Forte, G.Botti, R.Franco, A.La Rocca*, G.Rocco* Istituto Nazionale Tumori Napoli Dip.Anatomia Patologica; Dip.Onc.Sperimentale^;
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
The ulcer of gastric stump: a case-control study Coordinators: Author: Roxana Spac Dr.Anca Negovan Drd. Monica Pantea Co-author: Dr Nina Sincu Andreea.
NEOPLASMS OF THE STOMACH
Gastric Cancer Gidon Almogy MD Department of General Surgery Hadassah University Hospital.
INCREASED EXPRESSION OF PROTEIN KINASE CK2  SUBUNIT IN HUMAN GASTRIC CARCINOMA Kai-Yuan Lin 1 and Yih-Huei Uen 1,2,3 1 Department of Medical Research,
A 58 years old man presents with melena. What would you ask him?
Role of CXCR4 and VEGF expression and metastatic locoregional lymphnodes in rectal carcinoma Tatangelo F.*, Avallone A.**, Delrio P.°, Scala S.§, Botti.
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
53 y/o Upper abd pain/burning, reflux 9/2011 – EGD – polypoid lesion in stomach on EGD, started on omeprazole – Path – carcinoid, invasive to muscularis,
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
MALIGNANT POLYPS DURING THE FIRST THREE SCREENING ROUNDS ( ) FOR COLON-RECTAL CANCER (CRC) IN A NORTH-EASTERN SANITARY DISTRICT (ULSS-1 VENETO).
Pathology.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
NEOPLASIA Dr. Manal Maher Hussein.
위암병리보고서의 기재사항 서울대학교 김 우 호.
Case 1 현 O 훈 (M/34). Diagnosis : Stomach, distal gastrectomy: Signet ring cell carcinoma 1) Location: Angle 2) Tumor gross type: Early.
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
Association of Family History with Cancer Recurrence and Survival in Patients with Gastric Cancer Journal of Clinical Oncology : R2 Hwang.
Review R4 황은정 경희대학교 의과대학 소화기내과.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 5 : 2013 F1 김태영 Katsuhiko Higuchi, MD, PhD, Satoshi Tanabe, MD, PhD, Mizutomo Azuma, MD, PhD, Chikatoshi Katada,
Kyung Hee University, Seoul, Korea Conference LGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
1 Motohiko Kato, Tsutomu Nishida, Katsumi Yamamoto, Shiro Hayashi, Shinji Kitamura, Takamasa,Yabuta, Toshiyuki Yoshio, Takeshi Nakamura, Masato Komori,6.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
GI conference Case 3 Stomach and liver F/69 S
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.
Eradication of Helicobacter pylori After Endoscopic Resection of Gastric Tumors Does Not Reduce Incidence of Metachronous Gastric Carcinoma Clinical Gastroenterology.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
Department of Pathology R3 NKY Case 1.
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
Review R4 황은정 / prof. 장영운 경희대학교 의과대학 소화기내과.
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Gastric Cancer Pathology. Malignant Neoplasms of the Stomach Primary Adenocarcinoma (94%) Lymphoma (4%) Malignant GIST (1%) Haematogenous spread Breast.
Kyung Hee University, Seoul, Korea GI Conference UGI Conference Presented by Byeong-Joo Noh Supervised by Youn-Wha Kim Kyung Hee University, Seoul, Korea.
Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2,
Dr.Amit Gupta Associate Professor Dept. of Surgery
Volume 26, Issue 1, Pages 8-12 (March 2017)
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Nonpolypoid (Flat and Depressed) Colorectal Neoplasms
STOMACH CANCER BY DR: ALI ALWAILY/MD.
Predicting nodal metastasis among oral cancer patients
Depth of Submucosal Invasion Does Not Predict Lymph Node Metastasis and Survival of Patients With Esophageal Carcinoma  Rami J. Badreddine, Ganapathy.
Changes in TNM 8 To be used from
Neuroendocrine tumours of the stomach
Presentation transcript:

Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee Presented by intern 張家維 Histopathology 2005, 46, 158–165.

Introduction 2nd most common cause of cancer deaths East Asia and south America Korea and Japan  early detection Early Gastric Carcinoma Mucosa or Submucosa 5-year survival rate Lymph node metastasis prognosis, submucosal invasion

Introduction Depth of submucosal layer viaries The depth of submucosal gastric carcinoma (SMGC) Lymph node metastasis macroscopic appearance, location, size, tumor area, differentiation, invasion depth, submucosal vascularity, fibrosis near the tumor area Age- and Sex- matched

Materials and methods Sampling: 248 patients SMGC Surgical resection Samsung Medical Centre (Seoul, Korea) 1995/Jan.~ 2002/Oct. Total 917 patients SMGC 124 LN metastasis (13.5%) Anticancer therapy X Evidence of metastatic disease X

Materials and methods 124 SMGC with LN metastasis 124 SMGC without LN metastasis Age- and Sex- matched Specimens  routinely examined 10% formalin Embedded in paraffin H & E stained

Materials and methods Macroscopic: Japanese Endoscopic Society Classification Elevated, Depressed, Flat Microscopic: Lauren classification

Materials and methods Depth of submucosal invasion 1.Ocular lens scale, distance between the lower edge of the muscularis mucosa and the deepest invading front of the tumor cells 2.sm3 method: sm1, sm2, sm3 3.sm2 method: sm i, sm e

Materials and methods Tumor size Longest dimension of the tumor area Tumor area Longest dimension X its prependicular counterpart Tumor vessels vessels with a smooth muscle coat in the submucosa

Materials and methods Statistical analysis: Log linear model, McNemar’s test, A paired t-test, Wilcoxon’s signed rank test P-value < 0.05  statistically significant SAS, version 6.12

Results Pathological parameters and lymphnode metastatic disease 124 SMGC with lymph node metastasis 69 males (55.6%), 55 females (44.4%) 31~83 y/o, the mean age 56.3 y/o The main locations of the tumors 60 lower, 61 middle, 3 upper 1/3 Tumor size 5~125 mm, the mean = 45 mm Tumor area 0.8~105.0 cm2, the mean = 17.1 cm2

Results Pathological parameters and lymphnode metastatic disease The gross types of the tumors 35 elevated (28.2%), 85 depressed (68.5%), 4 flat (3.2%) The histological differentiations (Lauren’s) 53 intestinal (42.7%), 65 diffuse (52.8), 6 mixed (4.8%) 111 N1 (89.5%), 13 N2 (10.5%)

Results Pathological parameters and lymphnode metastatic disease Significantly associated with node-positive SMGC 1. presence of lymphatic tumor emboli 2. a larger tumor area 3. a larger tumor size 4. a non-flat gross type 5. an increased vascularity No significant relationship 1. location 2. Lauren classification 3. tumor related fibrosis

Results Depth-related parameters and lymph node metastatic disease Ocular scale-measured depth 1. proved to have a significant correlation with node-positive SMGC 2. superficial invasive, deeply invasive (2mm) The sm3 method not well correlated The sm2 method not well correlated

Results Multivariate analyses for possible indicators of LN metastatic disease Multivariate logistic regression analysis location, gross type, Lauren’s classification, lymphatic tumor emboli, increased vascularity, tumor-related fibrosis, tumor size, depth (sm2 method) The incidence of lymph node metastatic disease increased in the presence of lymphatic tumor emboli and in the tumors that invaded more than half of the submucosal layer

Discussion EGC, the “early” horrible disaster  curable disease early diagnosis and treatment programs The term of EGC has 2 innate defect 1. lymph node metastatic diseases 2. discriminate submucosal tumor call invasion 5-year survival rate 93~99% for node-negative EGC 73~90% for node-positive EGC 90~100% for intramucosal confinement 73~90% for submucosal invasion

Discussion The treatment now for EGC conducting minimally invasive surgical procedures  endoscopic mucosal resection, laparoscopic partial resection need careful and intensively subclassification Remove all metastatic lymph nodes ? chance of a cure↓ Factors related to lymph node metastatic disease

Discussion SMGC lymph node metastasis rate 10~25% 917 SMGC in this tiral 13.5% LN metastasis The parameters related to LN metastasis lymphatic tumor emboli (uni- or multi- variate analysis) depth-related (accurate invasion depth, sm2 method)

Discussion The best way to represent a submucosal tumor invasion Tsuchiya et al. = sm3 not appropriate for classifying tumor from endoscopic biopsy specimen Yasuda et al. = accurately the depth submucosal tumor invasion of locally resected tumor > 300μm  gastrectomy + LN dissection Japanese Classification of Gastric Cancer criteria (0.5mm) depth of submucosal tumor invasion < 0.5mm  sm1 depth of submucosal tumor invasion > 0.5mm  sm2

Discussion Univariate analysis accurate depth of tumor invasion Multivariate analysis relative depth of tumor invasion Both accurate depth and relative depth of tumor invasion are important in predicting LN metastasis of SMGC A small group of superficial submucosal tumor invasions (even <1mm) presented LN metasitasis

Discussion In general, EGC with LN metastasis large, depressed growth (or ulcer), poorly differentiated adenocarcinoma associated with peptic ulceration Tumor size contact with submucosal lymphatics and venules Vascularity higher incidence in node-positive SMGC LN metastasis might be associated with tumor cells coming into contact with submucosal lymphatic and venules

Discussion Lymphatic tumor invasion and deeper tumor invasion into the submucosa simple and easy parameters for predicting LN metastasis from limited surgery specimens Small group of superficial involvement of submucosa LN metastasis Carefully selected patients for minimalizing operation Pathologist should carefully investigate the lymphatic invasion and the depth of tmor invasion

Characteristics of intramucosal gastric carcinoma with lymph node metastatic disease S Y Song, S Park,2 S Kim,3 H J Son1 & J C Rhee1 Presented by intern 張家維

Results macroscopic appearance location size differentiation presence of ulceration vascularity presence of gastritis cystica profunda-like glandular proliferation disruption of the muscularis mucosae and invasion into the muscularis mucosae

Results diffuse type histology (P < 0.001) and deep invasion into the muscularis mucosae (P < 0.05) were indicators of node-positive intramucosal EGCs

Conclusions These histological indicators are easily accessible and seem to predict lymph node metastatic disease in limited surgical specimens. Patients should be carefully selected despite the recent trend toward less invasive resection of EGCs, especially for those apparently confined to the mucosa.

Thank you for your attention